UnitedHealthcare's Medicare Fraud Investigation: Billions in Taxpayer Costs and a 50% Stock Drop

UnitedHealthcare Under Criminal Investigation for Medicare Fraud UnitedHealth Group, one of the nation's largest health insurers, is facing a criminal investigation for possible Medicare fraud. The investigation, which began last summer, focuses on the company's Medicare Advantage business practices. According to The Wall Street Journal, the investigation centers on allegations of misdiagnosing patients to increase reimbursements. The practice has reportedly added billions to taxpayer costs. "Medicare Advantage insurers are paid extra for covering sicker patients, creating an incentive to document diagnoses for patients they cover. In some cases, the Journal's reporting has shown, questionable diagnoses by UnitedHealth added billions to taxpayers' costs." - The Wall Street Journal The probe is not limited to Medicare fraud. It also includes inquiries into potential antitrust violations and a civil investigation of Medicare billing practices at the company's doctor's offices. The news comes as UnitedHealth's stock price has plummeted by 50% in the past month. This investigation highlights the significant financial and ethical implications of healthcare practices. The outcome will undoubtedly impact the future of Medicare Advantage programs and the insurance industry as a whole.